Anzeige
Meldung des Tages: Insider kaufen kräftig zu – 421.670 CAD an Käufen, während Silber $88 erreicht

Mereo Biopharma Aktie (ADR) News

Aktie
WKN:  A2PEYJ ISIN:  US5894921072 US-Symbol:  MREO Branche:  Biotechnologie Land:  Großbritannien
0,3887 $
+0,0033 $
+0,86%
0,34047 € 13.03.26
Depot/Watchlist
Marktkapitalisierung *
1,52 Mrd. €
Streubesitz
29,08%
KGV
-8,20
Faktor
0.2
Originalaktie
GB00BZ4G2K23

Mereo Biopharma Group Aktie (ADR) News

12.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
12.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
12.03.26 - PR Newswire
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO PR Newswire
11.03.26 - PR Newswire
MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
11.03.26 - PR Newswire
LEVI & KORSINSKY, LLP: CEO AND CSO NAMED AS CONTROL PERSON DEFENDANTS IN MEREO BIOPHARMA SECURITIES ACTION
LEVI & KORSINSKY, LLP: CEO AND CSO NAMED AS CONTROL PERSON DEFENDANTS IN MEREO BIOPHARMA SECURITIES ACTION PR Newswire
10.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
10.03.26 - PR Newswire
Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm PR Newswire
06.03.26 - PR Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
06.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
05.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
04.03.26 - PR Newswire
LEVI & KORSINSKY, LLP: CHRONOLOGY OF EVENTS IN THE MEREO BIOPHARMA SECURITIES CLASS ACTION
LEVI & KORSINSKY, LLP: CHRONOLOGY OF EVENTS IN THE MEREO BIOPHARMA SECURITIES CLASS ACTION PR Newswire
03.03.26 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO PR Newswire
02.03.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
02.03.26 - PR Newswire
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO PR Newswire
27.02.26 - PR Newswire
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire
26.02.26 - PR Newswire
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit PR Newswire
26.02.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - ...
25.02.26 - PR Newswire
LEVI & KORSINSKY, LLP: MEREO BIOPHARMA SECURITIES FILINGS ALLEGEDLY CONTAINED MISLEADING CLINICAL TRIAL DISCLOSURES
LEVI & KORSINSKY, LLP: MEREO BIOPHARMA SECURITIES FILINGS ALLEGEDLY CONTAINED MISLEADING CLINICAL TRIAL DISCLOSURES PR Newswire
24.02.26 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO PR Newswire
23.02.26 - PR Newswire
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO PR Newswire

Newssuche

Videos

newspaper
13.03.26 -3,08%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »